Itovebi (inavolisib) And The Risk Of Life-threatening Ketoacidosis

ITOVEBI (inavolisib), a cancer medication distributed across Canada, is being recalled due to new safety information about the risk of life-threatening ketoacidosis. The drug's labeling is being updated to reflect this serious side effect. This recall affects all patients who have received or may receive this medication.

Product

ITOVEBI (inavolisib)

Reason

New safety information - Labelling

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2025-10-09

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/d5972b9c-f61b-4670-bb2c-9de77129cc75